Edward B. Smith III - Dec 30, 2021 Form 4 Insider Report for HEAT BIOLOGICS, INC. (NHWK)

Role
Director
Signature
/s/ Edward B. Smith III
Stock symbol
NHWK
Transactions as of
Dec 30, 2021
Transactions value $
$0
Form type
4
Date filed
1/3/2022, 04:19 PM
Previous filing
Dec 15, 2021
Next filing
Dec 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHWK Stock Option (right to buy) Other $0 -32.5K -100% $0.00* 0 Dec 30, 2021 Common Stock 32.5K $4.06 Direct F1
transaction NHWK Stock Option (right to buy) Award $0 +32.5K $0.00 32.5K Dec 30, 2021 Common Stock 32.5K $4.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 30, 2021, the board of directors of Heat Biologics, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Mr. Smith on December 13, 2021 covering 32,467 shares under the Company's 2018 Stock Incentive Plan (the "Plan") and granted new stock options under the Plan, on substantially similar terms to the rescinded stock options, which new stock options are subject to forfeiture in the event an amendment to increase the number of shares of common stock available for grant under the Plan is not adopted by the Company's stockholders.
F2 These stock options vest pro rata on a monthly basis over a twelve- month period commencing 1/13/2022.